
1. nat commun. 2014 nov 25;5:5521. doi: 10.1038/ncomms6521.

pyrazoleamide compounds potent antimalarials target na+ homeostasis in
intraerythrocytic plasmodium falciparum.

vaidya ab(1), morrisey jm(1), zhang z(2), das s(1), daly tm(1), otto td(3),
spillman nj(4), wyvratt m(5), siegl p(5), marfurt j(6), wirjanata g(6), sebayang 
bf(7), price rn(8), chatterjee a(9), nagle a(9), stasiak m(2), charman sa(10),
angulo-barturen i(11), ferrer s(11), belén jiménez-díaz m(11), martínez ms(11),
gamo fj(11), avery vm(12), ruecker a(13), delves m(13), kirk k(4), berriman m(3),
kortagere s(1), burrows j(5), fan e(2), bergman lw(1).

author information: 
(1)department microbiology immunology, center molecular parasitology, 
drexel university college medicine, 2900 queen lane, philadelphia,
pennsylvania 190129, usa.
(2)department biochemistry, university washington, box 357350, seattle,
washington 98195, usa.
(3)wellcome trust sanger institute, hinxton, cambridge cb101sa, uk.
(4)research school biology, australian national university, canberra,
australian capital territory 0200, australia.
(5)medicines malaria venture, po box 1826, 20rt de pr-bois, geneva 15 1215,
switzerland.
(6)division global tropical health, menzies school health research 
charles darwin university, po box 41096, casuarina, northern territory 0811,
australia.
(7)eijkman institute molecular biology, jl. diponegoro 69, jakarta 10430,
indonesia.
(8)1] division global tropical health, menzies school health research
and charles darwin university, po box 41096, casuarina, northern territory 0811, 
australia [2] nuffield department clinical medicine, centre tropical
medicine, university oxford, oxford ox3 7lj, uk.
(9)genomics institute novartis research foundation, 10675 john jay hopkins
drive, san diego, california 92121, usa.
(10)center drug candidate optimisation, monash university, 381 royal parade, 
parkville, victoria 3052, australia.
(11)glaxosmithkline, malaria support group, calle severo ochoa 2, tres cantos
28760, spain.
(12)eskitis institute, griffith university, young road, nathan, queensland
4111, australia.
(13)department life sciences, south kensington campus, imperial college,
london sw7 2az, uk.

the quest new antimalarial drugs, especially novel modes of
action, essential face emerging drug-resistant parasites. we
describe new chemical class molecules, pyrazoleamides, potent activity 
against human malaria parasites showing remarkably rapid parasite clearance
in vivo model. investigations involving pyrazoleamide-resistant parasites, 
whole-genome sequencing gene transfers reveal mutations two proteins,
a calcium-dependent protein kinase (pfcdpk5) p-type cation-atpase (pfatp4),
are necessary impart full resistance compounds. pyrazoleamide
compound causes rapid disruption na(+) regulation blood-stage plasmodium 
falciparum parasites. similar effect na(+) homeostasis recently reported
for spiroindolones, antimalarials chemical class quite distinct
from pyrazoleamides. results reveal disruption na(+) homeostasis in
malaria parasites promising mode antimalarial action mediated least
two distinct chemical classes.

doi: 10.1038/ncomms6521 
pmcid: pmc4263321
pmid: 25422853  [indexed medline]

